Will the FDA grant approval for any GLP-1 receptor agonist medication for the treatment of at least one substance use disorder by December 31, 2029?

Prediction taken (and slightly adapted) from here:
https://recursiveadaptation.com/p/addiction-predictions-for-2025-and

Resolution: This market will resolve as 'Yes' if the FDA issues formal approval for any GLP-1 receptor agonist to treat any form of substance use disorder as listed in DSM-5, including but not limited to alcohol use disorder, opioid use disorder, or cocaine use disorder. The approval must be specifically for treating the substance use disorder, not for other indications like obesity or diabetes.

(this is my first question - in case clarification is needed please message/comment!)